Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by HeartFlow Holding, Inc.
HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease
July 18, 2024
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
SCCT 2024: HeartFlow to Present New Data on Coronary Artery Disease Management with Coronary Computed Tomography Angiography
July 16, 2024
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
HeartFlow AI Plaque Analysis Achieves Major Milestone Towards Medicare Coverage
June 03, 2024
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study
May 15, 2024
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients
May 08, 2024
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
HeartFlow Initiates DECIDE Registry to Evaluate Utility of HeartFlow AI-Enabled Plaque Analysis for Patients with Suspected Coronary Artery Disease
March 26, 2024
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journal of Cardiovascular Computed Tomography
March 12, 2024
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
HeartFlow Announces New Reimbursement Code and Increased Payment for FFRCT
January 23, 2024
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
HeartFlow Achieves Landmark Milestone of 250,000 Patients Assessed for Coronary Artery Disease (CAD) with FFRCT Analysis
January 03, 2024
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
TCT 2023: HeartFlow Presents Clinical Data Featuring First Solution Offering Lesion-Specific Insights
October 25, 2023
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
New Data from Clinical Studies Further Validate HeartFlow’s All-in-One Portfolio of Precision Coronary Care Solutions
July 28, 2023
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
HeartFlow, Inc. to Announce New Data on Diagnosing and Managing Coronary Artery Disease at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting
July 24, 2023
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
New HeartFlow RoadMap™ Analysis Now Available in U.S. to Assist CT Readers in Identifying Coronary Artery Narrowings
April 17, 2023
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
HeartFlow, Leader in Revolutionizing Precision Heart Care, Closes $215 Million in Series F Funding Led by Bain Capital Life Sciences
April 06, 2023
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
CORRECTION -- Late-breaking Data Demonstrate AHA/ACC Guideline-directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing
November 06, 2022
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
Late-breaking Data Demonstrate AHA/ACC Guideline-directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing
November 06, 2022
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
HeartFlow Receives FDA 510(k) Clearance for its Plaque Analysis and RoadMap™ Analysis
October 18, 2022
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
HeartFlow Announces Late Breakers Presentation at the 2022 American Heart Association (AHA) Scientific Sessions
October 03, 2022
From
HeartFlow Holding, Inc.
Via
GlobeNewswire
HeartFlow Holding, Inc. Provides Selected Preliminary Second Quarter 2021 Financial Results and Updated Guidance for Full Year 2021
September 14, 2021
From
HeartFlow Holding, Inc.
Via
Business Wire
HeartFlow, the Leader in Precision Heart Care, Announces Merger with Longview Acquisition Corp. II to Become a Publicly Traded Company
July 15, 2021
From
HeartFlow Holding, Inc.
Via
Business Wire
Tickers
LGV
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.